Vaxart, Inc. (VXRT)
0.4344
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Vaxart Price : 0.4344 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 0.44 | 0.45 | 0.431 | 0.4344 | 198223.0 |
| Oct 08, 2026 | 0.44 | 0.44 | 0.4315 | 0.4345 | 267426.0 |
| Oct 07, 2026 | 0.4306 | 0.4400 | 0.401 | 0.432 | 354923.0 |
| Oct 06, 2026 | 0.42 | 0.45 | 0.415 | 0.4363 | 121056.0 |
| Oct 05, 2026 | 0.435 | 0.4473 | 0.40 | 0.42 | 329590.0 |
| Oct 02, 2026 | 0.4535 | 0.46 | 0.4301 | 0.437 | 239377.0 |
| Oct 01, 2026 | 0.45 | 0.4623 | 0.4306 | 0.44 | 339926.0 |
| Sep 30, 2026 | 0.45 | 0.4635 | 0.43 | 0.45 | 161720.0 |
| Sep 29, 2026 | 0.454 | 0.4693 | 0.44 | 0.4502 | 297712.0 |
| Sep 28, 2026 | 0.45 | 0.46 | 0.44 | 0.4578 | 124977.0 |
| Sep 25, 2026 | 0.4501 | 0.4765 | 0.45 | 0.4548 | 303712.0 |
| Sep 24, 2026 | 0.4799 | 0.4899 | 0.45 | 0.452 | 443257.0 |
| Sep 23, 2026 | 0.4801 | 0.50 | 0.45 | 0.4798 | 243817.0 |
| Sep 22, 2026 | 0.4805 | 0.494 | 0.4601 | 0.4844 | 334853.0 |
| Sep 21, 2026 | 0.4803 | 0.50 | 0.467 | 0.492 | 124976.0 |
| Sep 18, 2026 | 0.4809 | 0.49 | 0.48 | 0.486 | 148314.0 |
| Sep 17, 2026 | 0.47 | 0.50 | 0.465 | 0.4999 | 324960.0 |
| Sep 16, 2026 | 0.48 | 0.48 | 0.4501 | 0.474 | 247761.0 |
| Sep 15, 2026 | 0.4999 | 0.4999 | 0.45 | 0.48 | 617116.0 |
| Sep 14, 2026 | 0.50 | 0.52 | 0.4801 | 0.49 | 264872.0 |
| Sep 11, 2026 | 0.475 | 0.50 | 0.475 | 0.485 | 45290.00 |
| Sep 10, 2026 | 0.485 | 0.4987 | 0.4661 | 0.4870 | 198347.0 |
| Sep 09, 2026 | 0.49 | 0.5074 | 0.475 | 0.4884 | 272002.0 |
| Sep 08, 2026 | 0.4931 | 0.51 | 0.49 | 0.5037 | 293414.0 |
| Sep 04, 2026 | 0.50 | 0.51 | 0.4903 | 0.495 | 130592.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 414.87 |
| Anika Therapeutics, Inc. | 19.58 |
| BioCryst Pharmaceuticals, Inc. | 8.55 |
| Imunon, Inc. | 1.08 |
Price Related Metrics
| PE Ratio | 2.732 |
| PS Ratio | 0.4261 |
| Price to Book Value | 1.281 |
| Price to Free Cash Flow | 3.103 |
| Earnings Yield | 36.60% |
| Market Cap | 105.49M |
| Operating PE Ratio | 2.615 |
| Normalized PE Ratio | 2.732 |